SCHEDULE: Vanguard Group Amends STAAR Surgical Stake to 0%
Schedule 13G Amendment
The Vanguard Group filed an Amendment No. 8 to Schedule 13G for STAAR Surgical Co, reporting 0% beneficial ownership following an internal realignment.
Summary
- The Vanguard Group filed an Amendment No. 8 to Schedule 13G regarding its beneficial ownership in STAAR Surgical Co.
- As of March 13, 2026, The Vanguard Group reports 0 shares beneficially owned, representing 0% of the class of Common Stock (CUSIP 852312305).
- This change follows an internal realignment within The Vanguard Group on January 12, 2026.
- Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately (on a disaggregated basis) in reliance on SEC Release No. 34-39538 (January 12, 1998).
- The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, primarily a procedural change in how The Vanguard Group reports its beneficial ownership, with no direct positive or negative implications for STAAR Surgical Co's operational performance or valuation.
Positives
- The internal realignment allows for more granular reporting of beneficial ownership by Vanguard's subsidiaries, potentially increasing transparency for specific funds or divisions.
Negatives
- The Vanguard Group, Inc. no longer directly reports beneficial ownership of STAAR Surgical Co, which might require investors to track multiple filings from Vanguard's subsidiaries for a complete picture of Vanguard's overall exposure.
Risks
- Investors tracking The Vanguard Group's aggregate holdings in STAAR Surgical Co will need to monitor separate filings from Vanguard's subsidiaries or business divisions to understand the full scope of Vanguard-affiliated ownership.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that this filing reflects a procedural change in how a major institutional investor, The Vanguard Group, reports its holdings, rather than a change in investment strategy towards STAAR Surgical Co. Such internal realignments and subsequent reporting adjustments are not uncommon among large, diversified asset managers seeking to optimize compliance and transparency across their various funds and divisions.
Stakeholder Impact
- Shareholders of STAAR Surgical Co: The direct impact is minimal, as the underlying investment by Vanguard's various funds may still exist, just reported differently. It clarifies that The Vanguard Group, Inc. no longer holds a direct reportable stake.
- Investors tracking Vanguard: Will need to monitor filings from Vanguard's individual subsidiaries or business divisions to understand the aggregate beneficial ownership by Vanguard-affiliated entities.
Key Dates
| Date | Description |
|---|---|
| January 12, 1998 | Date of SEC Release No. 34-39538, which permits disaggregated reporting of beneficial ownership by certain entities. |
| January 12, 2026 | Date of internal realignment within The Vanguard Group, leading to changes in beneficial ownership reporting. |
| March 13, 2026 | Date of event which required the filing of this Schedule 13G Amendment, indicating 0% beneficial ownership by The Vanguard Group, Inc. |
| March 27, 2026 | Signature date of the Schedule 13G Amendment by The Vanguard Group. |
Keywords
STAAR Surgical Co, Vanguard Group, Schedule 13G, Beneficial Ownership, SEC Filing, Institutional Investor, Common Stock, Ownership Change, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.